Mediplus Expands POPY Pessary Range for Better Fit and Comfort
Expansion of Mediplus's POPY line to aid a greater number of women dealing with Pelvic Organ Prolapse
Mediplus Ltd, a leading medical device company, has announced an expansion of its POPY (Pelvic Organ Prolapse) pessary product line. The new addition includes five new sizes, bringing the total to 11 sizes, available in both short and long stem versions.
Enhanced Flexibility and Comfort
The expansion aims to provide greater flexibility in fitting, crucial for achieving optimal support and comfort for patients with varying anatomical needs. By offering a wider range of sizes, Mediplus aims to enhance patient satisfaction and treatment efficacy, ensuring pessaries fit as comfortably as possible.
A Growing Market
The vaginal pessaries market, including products like the POPY pessary, is projected to grow due to increasing awareness and acceptance of non-surgical treatments for conditions like pelvic organ prolapse. The expansion by Mediplus aligns with this trend, as the market is expected to grow at a CAGR of 5.7% from 2025 to 2035, with North America anticipated to hold a significant share during this period.
The rising prevalence of pelvic organ prolapse and urinary incontinence continues to drive demand for effective, non-surgical solutions such as vaginal pessaries.
Key Benefits of the POPY Pessary
- The POPY pessary is designed to be soft and flexible, ensuring easy fitting and removal.
- The material used in the POPY pessary reduces the risk of vaginal erosion, a common complication with harder pessaries.
- The POPY pessary offers significant cost savings compared to surgical interventions.
- The POPY pessary alleviates the symptoms of pelvic organ prolapse.
Commitment to Innovation and Patient-Centric Care
Mediplus is proud to offer an enhanced solution with the expanded POPY pessary size range. This expansion is part of Mediplus's ongoing commitment to innovation and patient-centric care.
In related news, Pelvital announced a landmark review paper on transvaginal mechanotherapy, and a pioneering tech to address threatened miscarriage has secured £1m funding. The busy summer for medtech policy continues.
With this expansion, Mediplus reaffirms its commitment to providing effective, conservative, and cost-effective solutions for women suffering from pelvic organ prolapse.
- The expansion of Mediplus's POPY pessary range, offering 11 sizes in both short and long stem versions, is a significant development in the realm of femtech news, aiming to improve women's health through scientific advancements in health-and-wellness and specifically women's health.
- By catering to varying anatomical needs, the new POPY pessaries not only support pelvic organ prolapse treatment but contribute to the growth of the vaginal pessaries market, which is expected to increase due to the acceptance and awareness of non-surgical treatments for such conditions.
